The onset and severity of acute opioid toxicity in heroin overdose cases: a retrospective cohort study at a supervised injecting facility in Melbourne, Australia

References

• Degenhardt L, Hall W. Extent of illicit drug use and dependence, and their contribution to the global burden of disease. Lancet. 2012;379(9810):55–70.
   PubMed Web of Science ®Google Scholar
• Degenhardt L, Day C, Dietze P, et al. Effects of a sustained heroin shortage in three Australian states. Addiction. 2005;100(7):908–920.
   PubMed Web of Science ®Google Scholar
• Roxburgh A, Hall WD, Dobbins T, et al. Trends in heroin and pharmaceutical opioid overdose deaths in Australia. Drug Alcohol Depend. 2017;179:291–298.
   PubMed Web of Science ®Google Scholar
• Scholl L, Seth P, Kariisa M, et al. Drug and opioid-involved overdose deaths - United States, 2013–2017. MMWR Morb Mortal Wkly Rep. 2018;67(5152):1419–1427.
   PubMedGoogle Scholar
• Wilson N, Kariisa M, Seth P, et al. Drug and opioid-involved overdose deaths - United States, 2017–2018. MMWR Morb Mortal Wkly Rep. 2020;69(11):290–297.
   PubMed Web of Science ®Google Scholar
• Gossop M, Stewart D, Treacy S, et al. A prospective study of mortality among drug misusers during a 4-year period after seeking treatment. Addiction. 2002;97(1):39–47.
   PubMed Web of Science ®Google Scholar
• Darke S, Mills KL, Ross J, et al. Rates and correlates of mortality amongst heroin users: findings from the Australian treatment outcome study (ATOS), 2001-2009. Drug Alcohol Depend. 2011;115(3):190–195.
   PubMed Web of Science ®Google Scholar
• Stam NC, Gerostamoulos D, Dietze PM, et al. The attribution of a death to heroin: a model to help improve the consistent and transparent classification and reporting of heroin-related deaths. Forensic Sci Int. 2017;281:18–28.
   PubMed Web of Science ®Google Scholar
• Degenhardt L, Bucello C, Mathers B, et al. Mortality among regular or dependent users of heroin and other opioids: a systematic review and Meta-analysis of cohort studies. Addiction. 2011;106(1):32–51.
   PubMed Web of Science ®Google Scholar
• Overdyk F, Dahan A, Roozekrans M, et al. Opioid-induced respiratory depression in the acute care setting: a compendium of case reports. Pain Manag. 2014;4(4):317–325.
   PubMedGoogle Scholar
• Strang J. Death matters: understanding heroin/opiate overdose risk and testing potential to prevent deaths. Addiction. 2015;110(2):27–35.
   Web of Science ®Google Scholar
• Jolley CJ, Bell J, Rafferty GF, et al. Understanding heroin overdose: a study of the acute respiratory depressant effects of injected pharmaceutical heroin. PLoS One. 2015;10(10):e0140995.
   PubMed Web of Science ®Google Scholar
• Dursteler-Mac Farland KM, Stormer R, Seifritz E, et al. Opioid-associated effects on oxygen saturation. Addiction. 2000;95(2):285–287.
   PubMed Web of Science ®Google Scholar
• Stoermer R, Drewe J, Dursteler-Mac Farland KM, et al. Safety of injectable opioid maintenance treatment for heroin dependence. Biol Psychiatry. 2003;54(8):854–861.
   PubMed Web of Science ®Google Scholar
• Macintyre PE, Loadsman JA, Scott DA. Opioids, ventilation and acute pain management. Anaesth Intensive Care. 2011;39(4):545–558.
   PubMed Web of Science ®Google Scholar
• White JM, Irvine RJ. Mechanisms of fatal opioid overdose. Addiction. 1999;94(7):961–972.
   PubMed Web of Science ®Google Scholar
• Warner-Smith M, Darke S, Lynskey M, et al. Heroin overdose: causes and consequences. Addiction. 2001;96(8):1113–1125.
   PubMed Web of Science ®Google Scholar
• Bowen J, Levy N, Macintyre P. Opioid-induced ventilatory impairment: current ‘track and trigger’ tools need to be updated. Anaesthesia. 2020;75(12):1574–1578.
   PubMed Web of Science ®Google Scholar
• Australian and New Zealand College of Anaesthetists and Faculty of Pain Medicine. Statement on principles for identifying and preventing opioid-induced ventilatory impairment (OIVI) in the acute pain setting. Victoria, Australia: Australian and New Zealand College of Anaesthetists and Faculty of Pain Medicine; 2018.
   Google Scholar
• Darke S, Mattick RP, Degenhardt L. The ratio of non-fatal to fatal heroin overdose. Addiction. 2003;98(8):1169–1171.
   PubMed Web of Science ®Google Scholar
• Stam NC, Pilgrim JL, Drummer OH, et al. Catch and release: evaluating the safety of non-fatal heroin overdose management in the out-of-hospital environment. Clin Toxicol. 2018;56(11):1135–1142.
   PubMed Web of Science ®Google Scholar
• deJong JL, Lee J, Grande A, et al. Positional asphyxia in Opioid-Related deaths: is it being overlooked? J Forensic Sci. 2020;65(6):2008–2012.
   PubMed Web of Science ®Google Scholar
• Rodda LN, Pilgrim JL, Di Rago M, et al. A cluster of Fentanyl-Laced heroin deaths in 2015 in Melbourne, Australia. J Anal Toxicol. 2017;41(4):318–324.
   PubMed Web of Science ®Google Scholar
• Lam T, Barratt MJ, Bartlett M, et al. Infrequent detection of unintentional fentanyl use via urinalysis among people who regularly inject opioids in Sydney and Melbourne, Australia. Addiction. 2022;117(8):2331–2337.
   PubMed Web of Science ®Google Scholar
• Stam NC, Gerostamoulos D, Gerstner-Stevens J, et al. Determining the effective dose of street-level heroin: a new way to consider fluctuations in heroin purity, mass and potential contribution to overdose. Forensic Sci Int. 2018;290:219–226.
   PubMed Web of Science ®Google Scholar
• Frank RG, Pollack HA. Addressing the fentanyl threat to public health. N Engl J Med. 2017;376(7):605–607.
   PubMed Web of Science ®Google Scholar
• Fairbairn N, Coffin PO, Walley AY. Naloxone for heroin, prescription opioid, and illicitly made fentanyl overdoses: challenges and innovations responding to a dynamic epidemic. Int J Drug Policy. 2017;46:172–179.
   PubMed Web of Science ®Google Scholar
• Schumann H, Erickson T, Thompson TM, et al. Fentanyl epidemic in Chicago, Illinois and surrounding cook county. Clin Toxicol (Phila). 2008;46(6):501–506.
   PubMed Web of Science ®Google Scholar
• Sutter ME, Gerona RR, Davis MT, et al. Fatal fentanyl: one pill can kill. Acad Emerg Med. 2017;24(1):106–113.
   PubMed Web of Science ®Google Scholar
• Krotulski AJ, Chapman BP, Marks SJ, et al. Sentanyl: a comparison of blood fentanyl concentrations and naloxone dosing after non-fatal overdose. Clin Toxicol (Phila). 2022;60(2):197–204.
   PubMed Web of Science ®Google Scholar
• Strang J, McDonald R, Campbell G, et al. Take-Home naloxone for the emergency interim management of opioid overdose: the public health application of an emergency medicine. Drugs. 2019;79(13):1395–1418.
   PubMed Web of Science ®Google Scholar
• Bell A, Bennett AS, Jones TS, et al. Amount of naloxone used to reverse opioid overdoses outside of medical practice in a city with increasing illicitly manufactured fentanyl in illicit drug supply. Subst Abus. 2019;40(1):52–55.
   PubMed Web of Science ®Google Scholar
• Carpenter J, Murray BP, Atti S, et al. Naloxone dosing after opioid overdose in the era of illicitly manufactured fentanyl. J Med Toxicol. 2020;16(1):41–48.
   PubMed Web of Science ®Google Scholar
• Van Den Boom W, Del Mar Quiroga M, Fetene DM, et al. The Melbourne safe injecting room attracted people most in need of its service. Am J Prev Med. 2021;61(2):217–224.
   PubMed Web of Science ®Google Scholar
• Weeks A, Cogger S, Clark N. Initial experience with subcutaneous depot buprenorphine in a medically supervised injecting facility. Drug Alcohol Rev. 2021;40(7):1354–1355.
   PubMed Web of Science ®Google Scholar